Pharma News

Branded drugmakers weren't the only ones working through a tumultuous 2016. Generics companies faced pricing pressure...

• Drugmakers

Pharmaceutical companies spent €58.5m sponsoring doctors, patients organisations and healthcare providers last year, the Volkskrant said on Thursday.

• Health
• Pill

Astrazeneca led the way on the FTSE 100 this morning as London’s leading stock market index was on course to finish the week at a seven-week high.

• Pharmaceutical

A research report by DCAT Connect claims that the total global spend for pharmaceuticals through 2021 will increase by $367 billion on a constant-dollar basis,

• Pharmaceutical

Although saving money hasn’t been a priority for drug manufacturers in the past, with new healthcare reforms in action, many companies are looking at ways to stay within a budget. The development of a new drug costs an ...

• Pharmaceutical
• Big
• Data

In a bid to shore up its declining pharmaceutical exports, the commerce ministry is considering the proposal to supply generic drugs to the government of Myanmar.

• Drug
• Pharmaceutical

The Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMG-MAN) has commended the Senate President, Bukola Saraki for his intervention which led the Federal Government to introduce an Import Adjustment Tax policy.

• Pharmaceutical

The U.S. Food and Drug Administration said on Thursday it has approved Bayer AG's drug Stivarga to treat liver cancer, the first such approval in nearly a decade.

• Bayer

Ashland has agreed to acquire New Jersey-based Pharmachem Laboratories, a manufacturer of supplements and specialty ingredients for the wellness and personal care industries, for $660 million in cash.

• Ashland
• Pharmachem

The world's largest drugmaker just gave us a better idea of how drug price hikes impact its business.

• Drug

As drugmakers face growth challenges in the U.S. and other developed countries, China is looking more enticing to one CEO. Novartis chief Joe Jimenez thinks the market is set for a boom period as the industry launches a wave of new meds in the country.

• China
• Pharmaceutical

A new experiment conducted by a joint team of Russian and Swedish scientists has produced groundbreaking results in slowing down the ageing process of mice, raising hopes of the potential creation of an “anti-age” drug.

• Antioxidant

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi ...

• Drug
• Hepatitis

A year ago, Novartis inked a high-profile partnership with tech giant Qualcomm to develop a smart inhaler, in a clear bid to compete with its chief rival in the respiratory market, GlaxoSmithKline, which had formed a similar partnership with Propeller Hea

• Drug
• Pharmaceutical
• Health
• Respiratory

One-time Valeant enthusiast and hedge fund manager Bill Ackman has already lamented his huge bet on the now-imploded drugmaker as “one very big mistake.” But now, he’s going a step further, apologizing to investors for that mistake...

• Pharmaceutical

Roche surprised industry watchers on Tuesday when it placed a $65,000 list price on multiple sclerosis blockbuster-to-be Ocrevus, sparking comparisons with a more expensive—and less effective, according to trial data—Merck KGaA rival...

• Pharmaceutical

Vertex’s cystic fibrosis combo, Orkambi, hasn’t exactly torn up the market since hitting the scene in 2015. Now, though, the company has a new combo prospect it hopes can fare better—but the question is, how much?

• Pharmaceutical

U.S. pharma brands jumped in value almost across the board in Brand Finance's annual look at the nation’s most valuable. The lone exception? Valeant Pharmaceuticals

• Pharmaceutical

Warp Drive Bio has partnered with GSK to discover potential therapeutics in oncology and other diseases.

• Pharmaceutical

Oxford BioDynamics is participating in a collaboration to identify the biological factors that trigger disease relapses, known as flares, in Rheumatoid Arthritis (RA), entitled the BIO-FLARE study (Biological factors that limit sustained remission in Rheu

• Drug
• BioDynamics